The central drug regulator released two lists – one was a list of 48 drugs that failed the quality tests and another had ...

Biotechnology lets scientists engineer natural ingredients into products, often more sustainably than if they were farmed. Here's what to know.

According to DelveInsight’s analysis, the growth of the KRAS Inhibitors market is expected to be mainly driven by increasing incidence, a rise in awareness and access to treatment, and robust pipeline ...

Amid a flurry of weight loss readouts, a fresh-on-the-scene startup has come out with Phase I results showing weight loss at day 36 on par with or better than competitors, with few gastrointestinal ...

The Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard ...

One of the major dangers of taking substandard medications is the risk of prolonged health issues. PCM (paracetamol), for ...

Trinity plans to bring to market in 2025 Metabolomics Diagnostics' PrePsia test that can be used to determine preeclampsia risk in the 12th week of pregnancy.

In its latest drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has flagged ...

Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately ...

The CDSCO’s August 2024 report categorized several medications under its “Not of Standard Quality (NSQ Alert)” list, which ...

ASX falls on Wednesday with banks dragging down market. Lithium stocks surge on CATL suspension reports; MinRes jumps 16.2pc.